Objective: To quantify serum levels of intercellular adhesion molecule-1 (sICAM-1) and
vascular cell adhesion molecule-1 (sVCAM-1) in HIV/HCV coinfected patients to examine …

Background Relationship of hepatitis C virus (HCV) infection with an increased risk of
cardiovascular disease (CVD) in HIV-infected patients remains controversial. We evaluated …

Background. Successful hepatitis C virus (HCV) treatment may reduce cardiovascular
disease (CVD) risk and improve levels of CVD biomarkers produced outside the liver …

Abstract Objectives Hepatitis C virus (HCV) antiviral therapy might lead to decreased chronic
immune activation and endothelial dysfunction associated with cardiovascular risk. The aim …

The aim of this study was to evaluate the effect of antiretroviral therapy on inflammatory
markers of endothelial dysfunction in HIV treatment‐naïve infected patients. This was a …

Objectives Antiretroviral therapy (ART) in HIV‐infected patients is associated with increased
cardiovascular risk. Circulating markers of endothelial dysfunction may be used to study …

Elevated levels of inflammatory and endothelial biomarkers are related to chronic diseases,
cancers, and cardiovascular disease. This study aimed at evaluating the association of …

Background. The presence of the adhesion molecules intercellular adhesion molecule-1
(ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) is associated with …

Background: Hepatitis C virus (HCV) infection is associated with chronic inflammation; yet
studies show greater interleukin (IL)-6, but lower C-reactive protein (CRP) levels. We …

Although liver cirrhosis and hepatocellular carcinoma are major consequences of hepatitis
C (HCV), there has been an increasing number of studies examining extrahepatic …